Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Berberine wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
12 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mixed evidence
1 of 3 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Berberine and DHM have evidence — compare verdict strength side-by-side.
500mg 2-3x daily (1000-1500mg total)
With meals, Split into 2-3 doses
Berberine HCl capsules
300-600mg before or after drinking; 300mg daily for liver support
Before drinking alcohol, Before bed after drinking, Daily for liver support
Dihydromyricetin capsules or tablets
4-12 weeks
8-12 weeks
First 2 weeks
If on diabetes medications
Acute
Acute and ongoing
Next day
Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-Analysis
Phytotherapy research : PTR (2025) · Meta analysis · n=1337
For HbA1c, silymarin was more effective than resveratrol (MD -2.08, 95%Cl -3.50 to -0.72) (P < 0.05).
Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose-response meta-analysis of randomized clinical trials
Phytotherapy research : PTR (2023) · Meta analysis · n=1600
In addition, the non-linear analysis showed a significant lowering effect of berberine/barberry on IL-6 and TNF-α levels in doses <1000 mg/day and less than 5 weeks of intervention.
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
JAMA network open (2025) · Rct · n=113
The study included 113 patients with T2D (mean [SD] age, 54.3 [10.6] years; 72 male [63.7%]) who were randomized.
Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention
Cell proliferation (2023) · Systematic review
This review systematically illustrates that various polyphenols, including resveratrol, chlorogenic acid, caffeic acid, dihydromyricetin, quercetin, catechins, curcumin, etc., improve metabolic disorders through direct or indirect pathways to protect the liver and fight liver cancer.
Flavonoids-mediated SIRT1 signaling activation in hepatic disorders
Life sciences (2020) · Systematic review
Additionally, molecular modeling simulations were applied to explore the potential binding mode of these flavonoids to SIRT1.
Metabolic mechanisms of Dihydromyricetin and strategies for enhancing its bioavailability: A recent review
Food chemistry (2025) · Systematic review
It examines the key factors influencing its bioavailability and highlights the design and construction of various bio-based delivery systems aimed at improving its bioavailability.
Based on meta-analyses showing FPG reduction of 0.59-0.82 mmol/L and HbA1c reduction of 0.63%. Studies primarily used berberine HCl with low bioavailability. Effects require divided doses and may take 8-12 weeks.
Evidence primarily from systematic reviews examining polyphenol hepatoprotective mechanisms rather than direct DHM clinical trials. Bioavailability limitations may reduce actual effectiveness. Conservative estimates given lack of specific dose-response studies.
AI-estimated from published studies. Interpret as directional guidance.
Berberine has a higher evidence score (9/10 vs 7.5/10) and wins in 2 of 3 categories.
For reduce inflammation, Berberine has a higher relevance score (95 vs 75).
No known interactions between Berberine and DHM have been documented in our database. However, always consult a healthcare provider before combining supplements.